Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Liu X et al. - In a chronic disease such as glaucoma, a therapy that provides a long lasting local effect with minimal systemic side effects, while circumventing the issue of patient compliance, is very attractive. The field of gene therapy is growing rapidly and ocular applications are expanding.


Today in Basic Science/Genetics...keeping you current

Lack of association of two polymorphisms of IRF5 with Behcet's disease
Molecular Vision, 10/12/09

siRNA therapeutics for age-related macular degeneration: promises and pitfalls
Expert Review of Ophthalmology, 10/21/09

Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices
Journal of Cancer Research & Clinical Oncology, 10/23/09

Today in Glaucoma...keeping you current

Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09

Natural History of Open-Angle Glaucoma
Ophthalmology, 10/28/09

New devices in glaucoma surgery
Expert Review of Ophthalmology, 10/19/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address